Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection

Schaller M, Borelli C, Berger U, Walker B, Schmidt S, Weindl G, Jaeckel A (2009)
MEDICAL MYCOLOGY 47(7): 753-758.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Autor/in
; ; ; ; ; ;
Abstract / Bemerkung
Antimycotic nail lacquers are effective and safe for the treatment of onychomycosis. To assess the efficacy of three topical agents we studied the minimum inhibitory and fungicidal concentration of amorolfine, bifonazole and ciclopiroxolamine. Amorolfine showed the most effective fungistatic and fungicidal activity in vitro against seven clinical Trichophyton rubrum nail isolates, followed in descending order by ciclopiroxolamine and bifonazole. To mimic a nail infection more appropriately, the nail minimum fungicidal concentration (Nail-MFC) was determined in an onychomycosis model. Amorolfine and ciclopiroxolamine had Nail-MFCs ranging from 2-32 mu g/ml and 16-32 mu g/ml, respectively. In contrast, bifonazole was unable to kill T. rubrum in this model. Statistical analyses of the results show a significant difference between the two treatments with amorolfine and ciclopiroxolamine (P < 0.001). For amorolfine a mean concentration of 12.28 mu g/ml (95%-CI = [8.66, 17.41]) was sufficient to kill all strains, while for ciclopiroxolamine about twice that concentration was needed, i.e., 24.13 mu g/ml (95%-CI = [17.06, 34.13]). The individual sensitivity of six of the seven T. rubrum strains was higher for amorolfine. These data demonstrate that both amorolfine and ciclopiroxolamine effectively kill T. rubrum growing on nail powder and suggest a better cidal action for amorolfine. Further investigation would be required to determine if these in vitro data can partially explain the clinical observation of significantly higher cure rates in onychomycosis following a therapy with an amorolfine-containing nail lacquer formulation.
Stichworte
ciclopiroxolamine; Trichophyton rubrum; onychomycosis; nail infection; in vitro; Amorolfine; bifonazole
Erscheinungsjahr
2009
Zeitschriftentitel
MEDICAL MYCOLOGY
Band
47
Ausgabe
7
Seite(n)
753-758
ISSN
1369-3786
eISSN
1460-2709
Page URI
https://pub.uni-bielefeld.de/record/1589484

Zitieren

Schaller M, Borelli C, Berger U, et al. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. MEDICAL MYCOLOGY. 2009;47(7):753-758.
Schaller, M., Borelli, C., Berger, U., Walker, B., Schmidt, S., Weindl, G., & Jaeckel, A. (2009). Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. MEDICAL MYCOLOGY, 47(7), 753-758. doi:10.3109/13693780802577892
Schaller, M., Borelli, C., Berger, U., Walker, B., Schmidt, S., Weindl, G., and Jaeckel, A. (2009). Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. MEDICAL MYCOLOGY 47, 753-758.
Schaller, M., et al., 2009. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. MEDICAL MYCOLOGY, 47(7), p 753-758.
M. Schaller, et al., “Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection”, MEDICAL MYCOLOGY, vol. 47, 2009, pp. 753-758.
Schaller, M., Borelli, C., Berger, U., Walker, B., Schmidt, S., Weindl, G., Jaeckel, A.: Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. MEDICAL MYCOLOGY. 47, 753-758 (2009).
Schaller, Martin, Borelli, Claudia, Berger, Ursula, Walker, Birgit, Schmidt, Sybille, Weindl, Guenther, and Jaeckel, Andreas. “Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection”. MEDICAL MYCOLOGY 47.7 (2009): 753-758.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 19888808
PubMed | Europe PMC

Suchen in

Google Scholar